Martyn Bullock

Martyn Bullock is a Research Fellow at the University of Sydney's Sydney Medical School, affiliated with the Cancer Genetics Laboratory at the Kolling Institute. His research focuses on thyroid cancer mechanisms, molecular endocrinology, and translational diagnostics. Key areas include TERT promoter mutations, BRAF/RET pathway dysregulation, and liquid biopsy applications in clinical management. He has contributed to understanding genetic and epigenetic drivers of thyroid pathologies, including autoimmune interactions and therapeutic resistance.

His work spans experimental and clinical studies, utilizing mouse models to investigate gene deletions (e.g., FOXE1) and molecular signaling pathways. He has secured grants from organizations like the Endocrine Society of Australia and the American Thyroid Association, supporting projects on thyroid autoimmunity, drug resistance, and molecular diagnostic tools. Collaborations include multidisciplinary teams addressing thyroid cancer progression and novel treatment strategies.

Recent studies highlight advancements in liquid biopsies for prognosis assessment, polypharmacy effects on gut microbiota, and cardiac fibrosis mechanisms linked to nuclear receptors. His research bridges basic science and clinical application, with a focus on improving diagnostic accuracy and therapeutic outcomes for endocrine-related cancers and disorders.